Primary Record
timolol
- In stock
- 2,010 g
- Purity
- 99.2 %
- CAS
- 26839-75-8
Compound Identifiers & Properties
- CAS
- 26839-75-8
- PubChem CID
- 33624
- SMILES
- CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O
- Canonical SMILES
- CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1
Names & Synonyms
- timolol
- Betimol
- (S)-timolol
- Istalol
- Timopic
- Timololum
- Timoptic
- Timolol maleate
- Blocadren
- Timoptol
- Timacar
- Betim
- Timolol anhydrous
- Timolol GFS
- Temserin
- Aquanil
- Optimol
- Proflax
- Tenopt
- Phoxal-timolol
- arutimol
- Novo-Timol
- Nu-Timolol
- Timoptic OcuDose
- Apo-Timol
- Apo-Timop
- Timololo
- Timoptic-XE
- Timacor
- Azarga
- Nyogel
- Tiopex
- Timolol [USAN]
- Timololum [INN-Latin]
- Glau-opt
- S(-)-Timolol maleate
- L-Timolol
- S-Timolol
- Betimol (TN)
- Timolol (INN)
- Tim-AK
- (-)-Timolol
- Timolol hemihydrate
- Blocadren (TN)
- Timoptic (TN)
- Timoptic in Ocudose
- Istalol (TN)
- Timolol (TN)
- 26839-75-8
- Magnesium cyanamidate
- Nu-Timolol (TN)
- Timolol maleate salt
- Gen-Timolol (TN)
- Apo-Timol (TN)
- Apo-Timop (TN)
- Timolol [USAN:INN]
- Timoptic-XE (TN)
- PMS-Timolol (TN)
- Phoxal-timolol (TN)
- 5JKY92S7BR
- (S)-timolol (anhydrous)
- Tocris-0649
- CHEMBL499
- UNII-5JKY92S7BR
- TIMOLOL [HSDB]
- TIMOLOL [INN]
- AC1L1PYN
- Tim-AK (TN)
- TIMOLOL [MI]
- Prestwick0_000948
- Prestwick1_000948
- Prestwick2_000948
- Prestwick3_000948
- RefChem:898126
- GlyTouCan:G25766AE
- Lopac-T-6394
- Timoptic OcuDose. (TN)
- TIMOLOL [WHO-DD]
- D05UVD
- HSDB 6533
- AC1Q59QM
- SCHEMBL4912
- BLJRIMJGRPQVNF-JTQLQIEISA-N
- CHEBI:9599
- Lopac0_001189
- Oprea1_640981
- BSPBio_000916
- DTXSID4023674
- GTPL565
- Timolol Maleate, (1:1) Salt
- C13H24N4O3S
- ARONIS24479
- BIDD:GT0073
- EINECS 248-032-6
- SPBio_003075
- BPBio1_001008
- DTXCID203674
- ZINC2176
- CHEBI:39465
- CHEBI:60787
- CTK4F8602
- C07AA06
- S01ED01
- MK-950
- HMS2089I11
- HMS3259C20
- MK950
- (2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
- (S)-Timolol; Arutimol; L-Timolol
- CID33624
- G25766AE
- Tox21_110614
- BDBM50292219
- C13-H24-N4-O3-S
- EBC-26768
- NCGC00016798-06
- AKOS015969764
- Tox21_110614_1
- DB00373
- NC00592
- (-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole
- NCGC00016038-01
- NCGC00016038-02
- NCGC00016798-01
- NCGC00016798-02
- NCGC00016798-03
- NCGC00016798-05
- NCGC00016798-07
- NCGC00016798-08
- NCGC00016798-09
- NCGC00016798-11
- NCGC00016798-20
- NCGC00022033-02
- NCGC00022033-04
- NCGC00022033-05
- S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole
- DA-78480
- HY-17494
- J10.426D
- ST072193
- (S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
- (S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol
- CAS-26839-75-8
- CAS-26921-17-5
- LS-122231
- 817W3C6175
- AB00513729
- CS-0009238
- NS00115928
- C07141
- D08600
- AB00513729-17
- L-714,465
- 839T758
- EN300-17982937
- Q413994
- L-714503
- L714,465
- (2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
- BRD-K08806317-050-03-6
- BRD-K08806317-050-29-1
- BRD-K08806317-051-01-8
- BRD-K08806317-103-02-5
- L 714,465
- (2S)-1-(tert-butylamino)-3-{[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}propan-2-ol
- 2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (2S)-
- (2S)-3-[(tert-butyl)amino]-1-(4-morpholin-4-yl(1,2,5-thiadiazol-3-yl)oxy)propa n-2-ol
- (2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
- 2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (S)-
- 2-Propanol, 1-[(1,1-dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-, (2S)-
- 26921-17-5
- TIM
- (2S)-1-(tert-Butylamino)-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)-2-propanol
- (S)-1-(TERT-BUTYLAMINO)-3-((4-MORPHOLINO-1,2,5-THIADIAZOL-3-YL)OXY)-2-PROPANOL
- (S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
- (s)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-2-propanol
- (S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
- (S)-1-(tert-Butylamino)-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-2-propanol
- (S)-1-[(1,1-Dimethylethyl)amino]-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-2-propanol
- (S)-1-tert-Butylamino-3-(4-morpholin-4-yl-[1,2,5]thiadiazol-3-yloxy)-propan-2-ol
- [S,(-)]-1-(tert-Butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-2-propanol
- 1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol
- 2-Propanol, 1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-, (S)-(-)-
- (2S)-1-[(1,1-Dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-2-propanol
- (s)-1-[(1,1-dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-2-propanol
- (S)-Timolol; (2S)-1-[(1,1-Dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-2-propanol; 2-Propanol, 1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-, (S)-(-)- (8CI); 2-Propanol, 1-[(1,1-dimethylethyl)amino]-3-[[4-(4-mor
- 1-(tert-butylamino)-3-[4-(1,4-oxazinan-4-yl)-1,2,5-thiadiazol-3-yloxy]-(2S)-propan-2-ol
- 2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, hemihydrate, (S)-
- 2-Propanol, 1-[(1,1-dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-, (S)-
- 2-Propanol,1-[(1,1-dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-,(2S)-
- 248-032-6
- 29023-48-1